Riskpilot← Back to searchSign inGet full accessBOOST Pharma ApS
APSActiveCVR 41120495Nordre Fasanvej 215Research and experimental development on natural sciences and engineering · NACE 7210Est. 20202 employees
Revenue 2024
DKK -2,2M
+43% vs 2023
EBITDA margin
175.9%
-64% vs 2023
Equity ratio
-92.3%
Financial strength
Net profit 2024
DKK -4,3M
-55% vs 2023
| Revenue | DKK -2,2M | +43% |
| EBITDA | DKK -3,9M | -64% |
| Net profit | DKK -4,3M | -55% |
| Total assets | DKK 7,6M | +244% |
| Equity | DKK -7M | +23% |
| Employees | 2 | — |
Legal name
BOOST Pharma ApS
CVR number
41120495
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. januar 2020
Share capital
DKK 55.002
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at forske, udvikle og tilvejebringe lægemidler.
Address
Nordre Fasanvej 215
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -21 | -1.320 | -3.500 | -1.530 | -2.193 |
| Staff expenses | -0 | -694 | -1.087 | -825 | -1.665 |
| EBITDA | -21 | -2.014 | -4.587 | -2.355 | -3.859 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -21 | -2.014 | -4.587 | -2.355 | -3.859 |
| Net financials | -42 | -625 | -634 | -765 | -917 |
| Profit before tax | -63 | -2.638 | -5.221 | -3.120 | -4.775 |
| Tax | -0 | -414 | -1.023 | -366 | -516 |
| Net profit | -63 | -2.224 | -4.198 | -2.753 | -4.260 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3.683 | 7.823 | 4.314 | 2.217 | 7.625 |
| Equity | -23 | -2.248 | -6.446 | -9.199 | -7.040 |
| Long-term debt | 3.523 | 6.158 | 6.487 | 11.121 | 12.018 |
| Short-term debt | 184 | 3.913 | 4.272 | 295 | 2.647 |
| Total debt | 3.707 | 10.071 | 10.760 | 11.415 | 14.665 |
EBITDA margin
-385875300.0%
This company
15.8%
Market median
-2442248834% vs market
20202024
Equity ratio
-92.3%
This company
38.2%
Market median
-342% vs market
20202024
Return on equity
-425958300.0%
This company
18.4%
Market median
-2314990861% vs market
20202024
Net profit margin
-425958300.0%
This company
8.1%
Market median
-5258744544% vs market
20202024
Asset turnover
-0.29×
This company
1.12×
Market median
-126% vs market
20202024
Debt / equity
2.08×
This company
0.62×
Market median
-235% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-20 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AC Founder | Founder | 2020 | — | — |
HT Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
EJ Management | Management | 2024 | — | — |
LK | Founder | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
JÖ | Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 10.0% | 10.0% | 2025 | |
SAUNDERS HOLDING ApS | Company | 5.0% | 5.0% | 2021 |
| Individual | 20.0% | 20.0% | 2021 | |
| Individual | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BOOST Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Cecilia Götherström | Founder | 0 companies |
| Hans Thalsgård Schambye | Chief Executive Officer | 0 companies |
| Everhardus Johannes Joseph Kueppers | Management | 0 companies |
| Lilian Karin Florence Walter Jallow | Founder | 0 companies |
| Jonathan Jossi Ilicki | Board of Directors | 0 companies |
| Lars Magnus Reinhold Westgren | Board of Directors | 0 companies |
| Ingelise Saunders | Chairman | 0 companies |
| Jonas Jendi | Board of Directors | 0 companies |
| John Öhd | Board of Directors | 0 companies |